Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance

Internal Medicine

Volumn 50, Issue 7, 2011, Pages 707-712

  Inoue, Keita ^a   Takeshima, Fuminao ^a   Kadota, Koichiro ^a   Yoda, Aya ^a   Tatsuta, Yoichi ^a   Nagaura, Yuki ^a   Yoshioka, Sumako ^a   Nakamichi, Seiko ^a   Nakao, Kazuhiko ^a   Ozono, Yoshiyuki ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Insulin resistance; Smoking cessation; Weight gain

Indexed keywords

ADIPONECTIN; INSULIN; NICOTINE PATCH;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; UPREGULATION; VASODILATATION; WEIGHT CHANGE; WEIGHT GAIN;

ADIPONECTIN; ADULT; AGED; CAROTID ARTERIES; FOLLOW-UP STUDIES; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NICOTINE; SMOKING CESSATION; TRANSDERMAL PATCH; TUNICA INTIMA; TUNICA MEDIA; WEIGHT GAIN;

EID: 79953749764     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4600     Document Type: Article

References (24)

1. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 339: 1128-1130, 1992.
2. Campisi R, Czernin J, Schoder H, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 98: 119-125, 1998.
3. Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation-the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201: 225-235, 2008.
4. Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 22: 357-360, 1999.
5. Miyazaki T, Shimada K, Mokuno H, Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart 89: 663, 2003.
6. Iwashima Y, Katsuya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45: 1094-1100, 2005.
7. Otsuka F, Kojima S, Maruyoshi H, et al. Smoking cessation is associated with increased plasma adiponectin levels in men. J Cardiol 53: 219-225, 2009.
8. Efstathiou SP, Skeva II, Dimas C, et al. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis 205: 632-636, 2009.
9. Filozof C, Fernandez Pinilla MC, Fernandez-Cruz A. Smoking cessation and weight gain. Obes Rev 5: 95-103, 2004.
10. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med 46: 1079-1082, 2007.
11. Yoon C, Goh E, Park SM, Cho B. Effects of smoking cessation and weight gain on cardiovascular disease risk factors in Asian male population. Atherosclerosis 208: 275-279, 2010.
12. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002.
13. Xie XT, Liu Q, Wu J, Wakui M. Impact of cigarette smoking in type 2 diabetes development. Acta Pharmacol Sin 30: 784-787, 2009.
14. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298: 2654-2664, 2007.
15. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 27: 450-456, 1997.
16. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 9: 23-29, 2008; discussion 30-31.
17. Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2009: CD006219.
18. Perkins KA, Marcus MD, Levine MD, et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol 69: 604-613, 2001.
19. Spring B, Wurtman J, Wurtman R, et al. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation. Am J Clin Nutr 62: 1181-1187, 1995.
20. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustainedrelease bupropion and placebo for smoking cessation. N Engl J Med 337: 1195-1202, 1997.
21. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115, 1992.
22. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149-2155, 1993.
23. Esen AM, Barutcu I, Acar M, et al. Effect of smoking on endothelial function and wall thickness of brachial artery. Circ J 68: 1123-1126, 2004.
24. Johnson HM, Gossett LK, Piper ME, et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55: 1988-1995, 2010.